LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 33.80 | 21.74 | 1868 | 2381 | 0.7844 | 0.9296 | MN20160310_N01 | N03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 35.77 | 21.74 | 2309 | 2602 | 0.8871 | 0.9656 | MN20160310_N01 | K03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 35.77 | 21.74 | 2334 | 2602 | 0.8967 | 0.9687 | MN20160310_N01 | K03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 35.77 | 21.74 | 1992 | 2602 | 0.7653 | 0.9240 | MN20160310_N01 | N03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 35.77 | 21.74 | 2012 | 2602 | 0.7730 | 0.9268 | MN20160310_N01 | N03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 37.74 | 21.74 | 2484 | 2828 | 0.8782 | 0.9634 | MN20160310_N01 | K03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 37.74 | 21.74 | 2499 | 2828 | 0.8835 | 0.9651 | MN20160310_N01 | K03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 37.74 | 21.74 | 2089 | 2828 | 0.7386 | 0.9155 | MN20160310_N01 | N03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 37.74 | 21.74 | 2100 | 2828 | 0.7425 | 0.9170 | MN20160310_N01 | N03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 39.71 | 21.74 | 2640 | 3084 | 0.8560 | 0.9570 | MN20160310_N01 | K03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 39.71 | 21.74 | 2658 | 3084 | 0.8618 | 0.9588 | MN20160310_N01 | K03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 39.71 | 21.74 | 2337 | 3084 | 0.7578 | 0.9239 | MN20160310_N01 | N03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 39.71 | 21.74 | 2352 | 3084 | 0.7626 | 0.9256 | MN20160310_N01 | N03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 41.68 | 21.74 | 2860 | 3418 | 0.8366 | 0.9517 | MN20160310_N01 | K03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 41.68 | 21.74 | 2883 | 3418 | 0.8433 | 0.9538 | MN20160310_N01 | K03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 41.68 | 21.74 | 2525 | 3418 | 0.7386 | 0.9186 | MN20160310_N01 | N03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 41.68 | 21.74 | 2534 | 3418 | 0.7412 | 0.9196 | MN20160310_N01 | N03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 43.65 | 21.74 | 3105 | 3754 | 0.8271 | 0.9496 | MN20160310_N01 | K03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 43.65 | 21.74 | 3120 | 3754 | 0.8311 | 0.9508 | MN20160310_N01 | K03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 43.65 | 21.74 | 2798 | 3754 | 0.7453 | 0.9224 | MN20160310_N01 | N03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 43.65 | 21.74 | 2810 | 3754 | 0.7485 | 0.9235 | MN20160310_N01 | N03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 45.62 | 21.74 | 3410 | 4150 | 0.8215 | 0.9488 | MN20160310_N01 | K03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 45.62 | 21.74 | 3427 | 4150 | 0.8256 | 0.9501 | MN20160310_N01 | K03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 45.62 | 21.74 | 3063 | 4150 | 0.7379 | 0.9214 | MN20160310_N01 | N03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 45.62 | 21.74 | 3074 | 4150 | 0.7406 | 0.9223 | MN20160310_N01 | N03 |